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Summary 
Human  dendritic  cells  (DC)  can now be  generated in vitro in large  numbers by culturing 
CD34 + hematopoietic progenitors in  presence  of GM-CSF+TNFet for  12  d.  The present 
study demonstrates that cord blood CD34 + HPC indeed differentiate along two independent 
DC pathways. At early time points (day 5-7) during the culture, two subsets of DC precursors 
identified by the exclusive expression of CDla and CD14 emerge independently. Both precur- 
sor subsets  mature  at  day  12-14  into DC  with  typical morphology and phenotype (CDS0, 
CD83, CD86, CD58, high HLA class II). CDla + precursors give rise to cells characterized by 
the expression of Birbeck granules, the Lag antigen and E-cadherin, three markers specifically 
expressed on Langerhans cells in the epidermis. In contrast, the CD14 + progenitors mature into 
CDla + DC lacking Birbeck granules, E-cadherin, and Lag antigen but expressing CD2, CD9, 
CD68,  and the coagulation factor XIlla described in dermal dendritic cells.  The two mature 
DC were equally potent in stimulating allogeneic CD45RA + naive T  cells.  Interestingly, the 
CD14 + precursors, but not the CDla + precursors, represent bipotent cells that can be induced 
to differentiate, in response to M-CSF, into macrophage-like cells, lacking accessory function 
for T  ceils. 
Altogether, these results demonstrate that different pathways of DC development exist:  the 
Langerhans cells and the CD14+-derived DC related to dermal DC or circulating blood DC. 
The physiological relevance of these two pathways of DC development is discussed with regard 
to their potential in vivo counterparts. 
D 
endritic cells  (DC) 1 are professional antigen-present- 
ing cells that are required for the initiation of immune 
responses (1).  Present at trace levels in all organs, DC  are 
believed  to  function  as  sentinels  of the  immune  system. 
Many  types  of DC  with  subtle  differences in  phenotype 
have been  described in  peripheral blood,  skin,  and  lym- 
phoid organs. In peripheral blood three different subsets  of 
DC can be distinguished according to the expression of the 
surface antigens CD11c (2) or CD33 (3, 4) and CD83 (5). In 
the skin, epidermal Langerhans cells (LC) and the so-called 
t Abbreviations used in this paper: DC, dendritic cells; HPC, hematopoietic 
progenitor cells; LC, Landerhans cells. 
Preliminary results were presented  at the Third International  Symposium 
on Dendritic Cells, held in Annecy (France) in June 1994; and at the 
Keystone Meeting on Dendritic Cells, held in Taos (New Mexico) in 
March 1995. 
dermal dendrocytes (Birbeck granule-, factor XIIIa  +)  add 
some  diversity to  the  family of DC  (6,  7).  In  peripheral 
lymphoid  organs,  populations  with  different  localization 
and  phenotype  have  been  described  in  spleen  (8)  and 
Peyer's patches (9). Although each of these DC subsets dis- 
play  the  ability  to  activate  naive  T  cells,  it  is  not  clear 
whether they represent different stages  of maturation of a 
unique  DC  lineage  or whether they stem from different 
progenitors. In this respect, thymic DC in mice appear to 
originate from a hematopoietic progenitor with lymphoid 
but no myeloid potential (10). This subset might have been 
identified also  in humans  (11).  In contrast, DC  related to 
LC generated in vitro from hematopoietic progenitors, us- 
ing GM-CSF in mice (12-14) or GM-CSF+TNF~x in hu- 
man  (15-19)  appear to originate from a progenitor com- 
mon to monocytes and granulocytes.  Thus, different pathways 
of DC development may exist. 
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HPC  cultured with  GM-CSF+TNF0~ develop along two 
independent DC pathways that, after 5-7 d of culture, can 
be identified at an immature stage according to CDla and 
CD14  expression.  CDla  + precursors yield,  at  day  12-14, 
DC related to LC characterized by the expression of CDla, 
E-cadherin, Lag antigen and Birbeck granules. In contrast, 
CD14 + precursors yield, at day 12-14, DC related to der- 
mal dendrocytes or peripheral blood DC, characterized by 
the lack of Birbeck granules, E-cadherin, and Lag antigen 
and the expression ofCDla, CD2, CD9, CD68, and factor 
XIIIa. 
Materials and Methods 
Hematopoietic Factors.  rhGM-CSF  (specific activity:  2  ￿  10  a 
U/rag; Schering-Plough Research Institute, Kenilworth, NJ) was 
used at a saturating concentration of 100 ng/ml (200 U/ml). rhT- 
NFct  (specific activity:  2  ￿  107 U/rag; Genzyme, Boston, MA) 
was  used  at  an optimal concentration of 2.5  ng/ml (50  U/ml) 
(20)  rhSCF  (specific activity  4  ￿  105  U/mg; R&D,  Abington, 
UK) and rhM-CSF (specific activity: 2 ￿  106 U/mg; R&D) were 
used at optimal concentrations of 25 ng/ml. 
Collection and Purification of Cord Blood CD34  +  HPC.  Umbil- 
ical cord blood samples were obtained according to institutional 
guidelines. Cells bearing CD34 antigen were isolated from mono- 
nuclear fractions  (21, 22)  through positive  selection,  using anti- 
CD34 rnAb (Immu-133.3, Immunotech, Marseille,  France)  and 
goat anti-mouse lgG-coated microbeads (Miltenyi Biotec GnU.  H, 
Bergish  Gladbach,  Germany).  Isolation  of CD34  + progenitors 
was achieved  using Mimmacs separation  columns (Miltenyi Bio- 
tec  GmbH)  (23). In all experiments the isolated  cells were  80-- 
99% CD34 + as judged by staining with anti-CD34 mAb. After 
purification, CD34 + cells were cryopreserved  in 10% DMSO. 
Purification of Cord Blood and Adult Peripheral Blood CD45RA + 
T Cells.  Mononuclear cells were isolated from adult peripheral 
blood or cord blood and depleted of adherent cells by overnight 
adherence to plastic, in complete medium, at  1 ￿  l0  ~ cells per 
nil. CD45RA + T  lymphocytes were then purified by immuno- 
magnetic  depletion using a  cocktail  of mAbs  IOM2  (CD14), 
ION16 (CD16),  and ION2 (HLA-DR) (hnmunotech, Marseille, 
France);  NKH1  (CD56)  and  OKT8  (CD8)(Ortho  Diagnostic 
System,  P,  aritan,  NJ);  and 4G7  (CD19),  mAb 89,  (CD40)(24), 
and UCHL-1  (CD45R, O). After  two rounds of bead depletion, 
the purity of CD45P,  A + T cells was routinely higher than 95%. 
Liquid Cultures  for Dendritic Ceil Generation.  Cultures were es- 
tablished  in the presence  of SCF,  GM-CSF, and TNFo~, as de- 
scribed  (15, 18)  in endotoxin-free medium consisting of RPMI 
1640 (GIBCO BRL, Gaithersburg,  MD) supplemented with 10% 
(vol/vol) heat-inactivated fetal bovine serum (FBS) (Flow Labo- 
ratories,  Irvine, UK),  10 mM Hepes,  2  mM L-glutamine, 5  X 
10  s M  2-mercaptoethanol, penicillin (100  U/ml) and strepto- 
mycin (100 Ng/ml) (referred to as complete medium). 
After thawing, CD34 + cells were seeded for expansion in 25 to 
75 cm  2 falcons (Corning, New York; NK) at 2  ￿  104 cells/ml. 
Optimal conditions were maintained by splitting these cultures at 
day 4 with medium containing fresh GM-CSF and TNFo~ (cell 
concentration: 1-3  ￿  l0  s cells/ml).  For most experiments cells 
were routinely collected after 5-6 d of culture for FACS| 
holation qf CDIa and CDI4 DC Precursors by FACS| 
After 5-6 d of culture in presence ofSCF, GM-CSF, TNFo~, cells 
were  collected  and  labeled  with  FITC-conjugated  OKT6 
(CDla) (Ortho)  and  PE-conjugated  Leu-M3  (CD14)  (Becton 
Dickinson & Co., Mountain View, CA). Cells were separated ac- 
cording  to  CDla  and  CD14  expression  into  CD14+CDla  , 
CD14-CD1a  +,  and eventually CD14-CD1a-  fractions  using a 
FACStarplus |  (laser setting:  power,  250  roW; excitation wave- 
length, 488 nm; Becton Dickinson). All the procedures  of stam- 
irlg and sorting were performed in presence  of 5 mM EDTA in 
order to avoid cell aggregation..Reanalysis  of the sorted popula- 
tions showed a puri  W higher than 98%. 
Sorted cells were seeded in the presence  of GM-CSF+TNFcl 
(1-2  ￿  105 cells per ml) for 6-7 additional days, a last medium 
change being performed at day 10. Cells were routinely collected 
between day  11  and day  14. Eventually adherent cells were re- 
covered using a 5 mM EDTA solution. 
ProlferationAssay.  Cells at day 5-6 (CD14-CD1a +,  CD14 + 
CDla-, CD14-CDla-) and total populations were seeded at 3 ￿ 
10  4  cells per  well  in  round-bottomed microtest  tissue  culture 
plates  in presence  of medium alone,  GM-CSF,  TNFo~, GM- 
CSF+TNFot or M-CSF. After 3 d of culture, cells were pulsed 
with 1 btCi of 3H-TdR (specific activity 25 Ci/mmol) per well, 
for the last 8 h, harvested  and counted. Tests were carried out m 
triplicate,  and results were expressed as mean counts per minute 
(cpm) +  SD 
Cytofluorimetric Cell-Su{face Phenotypinq.  Cells were processed 
for double staining (day 6) or single staining (day 12 sorted popu- 
lations) using either uncoupled mAbs revealed  by phycoewthnn 
(PE)-conjugated sheep F(ab')2 anti-mouse inmmnoglobulin  (Ortho) 
or  biotinylated mAbs  revealed  by  PE-conjugated  streptavidin 
(Becton Dickinson) or PE-conjugated mAbs. For double staining, 
after  saturation  in  5%  mouse  serum,  cells were  stained  with 
OKT6  (anti-CDla)(Ortho)  or  Leu-M3  (anti-CDl4)(Becton 
Dickinson) mAbs directly labeled with FITC. Negative controls 
were performed with unrelated murine mAbs. Fluorescence  anal- 
ysis was determined with a FACScan  |  flow-cytometer (laser set- 
ting: power,  15  roW;  excitation wavelength, 488  nm; Becton 
Dickinson), 5,000  events and 10,000 to 50,000  events were col- 
lected for single and double staining, respectively. 
Immunostainings.  Cells were cytocentrifuged for 4 rain at 400 
rpm on a microscope slide. Some slides were used for May Griin- 
wald Giemsa staining and the others were fixed in methanol/ace- 
tone at 20~  for l  min for immunocytology. Slides were washed 
in PBS for  5 nfin and incubated with mAbs anti-CD68 (IgG3, 
Mo876,  Dako)  anti-Lag  (IgG1,  (25)) and  anti-S10013 (lgGl, 
$2532,  Sigma) and a rabbit polyclonal anti-Factor XllIa (Nordic 
Immunological  Laboratories,  Tilburg, Netherlands)  and mAh and 
polyclonal matched controls for 60 rain. The slides were washed 
twice in PBS. For CD68, slides were incubated with biotinylated 
sheep  anti-mouse IgG3 for 30 min (PB276u;  Binding Site, Bir- 
mingham, UK). For S100]3 and Lag, slides were incubated with 
biotinylated sheep anti-mouse IgG1 (PB273; Binding Site) for 30 
nfin. For Factor XIIIa, slides were  incubated with biotinylated 
goat anti-rabbit Ig (E432; Dako)  for 30 rain. All stainings were 
then incubated with streptavidin  coupled to alkaline phosphatase 
for 30 rain. The slides were washed  three times in PBS and the 
enzyme activity was developed by the fast red substrate (Dako). 
Electron Microscopy Proa'dures.  Cells were recovered  from  day 
6 to day 16. After washes, cells were directly fixed for  18 h with 
2% glutaraldehyde  in cacodylate buffer, then for l  h with I% os- 
mium tetroxide and embedded in epoxy medium after dehydra- 
tion through a graded series of ethanols.  Ultrathin sections were 
post-stained with uranyl acetate and lead citrate and examined on 
a JEOL 1200 EX electron microscope  (CMEABG, Universit6 de 
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was analyzed for the presence of Birbeck granules. 
T  Cell Proliferation Assay.  After 14 d  of culture, CDla +- and 
CD14+-derived  cells  were  collected  and,  after  irradiation  (30 
Gy), used as stimulator cells for allogeneic CD45RA + naive adult 
or cord blood T  cells (2 ￿  104 per well). From 10 to 104 stimula- 
tor cells were added to the T  cells in 96-well round-bottomed mi- 
crotest tissue-culture plates (Nunc, Roskilde, Denmark). Cultures 
were performed in RPMI 1640 medium supplemented with 10% 
heat-inactivated human AB + serum, and glutamine and antibiot- 
ics as above. After 5 d ofincubatiori, cells were pulsed with 1 ~Ci 
of 3H-TdR (specific activity 25 Ci/mmol) p~r well, for the last 8 h, 
harvested and counted. Tests were  carried out in triplicate, and 
results were  expressed as mean counts per rllitlute (cpm)  +  SD. 
The levels of 3H-TdR uptake by stimulator cells alone were al- 
ways below 100 cpm. 
Results 
Identification of Two DC Precursor Subsets Based on Exclusive 
Expression of CDla  and CD14.  In  previous  studies  we 
have reported  that cord blood CD34 + hematopoletic pro- 
genitor cells (HPC)  cultured for  12 d  m  presence of GM- 
CSF+TNF~  yield DC  characterized  by the  expression of 
CDla  (15).  As addition of SCF allows a  three-  to  fivefoid 
increase in cell numbers after 6  d  of culture without alter- 
ing cell differentiation (18,  and unpublished observations), 
SCF  was  added  from  day  0  to  day  6  in  all  cultures  per- 
formed along this study.  Herein,  we  have followed,  using 
double color fluorescence, the kinetic of CDla  and CD14 
expression during the  differentiation of CD34 + HPC  cul- 
tured in the presence of GM-CSF+TNFo~ (Fig.  1 A, n >30 
experiments). At day 0, CD34 §  cells express neither CDla 
nor CD14. At early time points (&iy 3  and 5), two popula- 
tions  characterized  by  the  exclusive  expression  of CDla 
and CD14  emerge independently, the  CD14 +  population 
being usually dominant over the CDla + population (mean 
1.8  +  0.8-fold, range 0.8-2.5). At day 7, a distinct popula- 
tion  of  double  positive  cells  can  be  identified  (3-8%), 
which reaches  a  maximum of 20--38% between day 8  and 
day  10.  The appearance of this double positive population 
correlates with the progressive disappearance of the CD 14 + 
CDla-  population, suggesting that the double positive cells 
stem from the CD14 + cells which acquire CDla,  From day 
10  to  day  12,  the  double positive population starts  disap- 
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Figure i.  Expression  Of CDla 
at~d C~14  or~  5--6  d  cUlttired 
CD34" HPC delineate two sub- 
populations of dendritic cell~. (M) 
Kinetics of GDia and CD14 ex- 
pressi0n dtlflng etlltt~te of CD34 + 
HPC irJ GM-C~P+TNFoL COld 
blood  CD34' HPC  were  cul- 
tured in presence of GM-CSF+ 
TNFo~ for  14  d.  At  the  time 
point indicated+ independent ali- 
quots of cells were recovered and 
cells were  processed for  double 
staining using anti-CD14-PE and 
anti-CDla-FITC. Quad were set 
up on the isotype matched con- 
trol dot plot+ 10,000 everit~ were 
acquired.  Numbers  represents 
ranges from more than 30 exper- 
iments.  (/3) Cord blood  CD34 + 
HPC were cultured for 5-6 d in 
presence  of  GM-CSF+TNF~x. 
Then  the  cells were  collected, 
processed for double staining us- 
ing  anti-CD14+PE  and  anti= 
CD1a-FITC ~nd FACg| 
into CDla+CDI4 - and CDI4 +- 
CDla-  (left panel). Sorted  cells 
were seeded in presence of GM- 
CSF+TNFa  (1-2  ￿  10  s  cells 
per ml) for 6--] additional days, a 
last medium change being per- 
formed at day 10. At day 12, cells 
were  reanalyzed  for  CDIa  and 
CD14  expressiori  by  double 
color  fluorescence  (right panel). 
Quad were set up on the is0type 
matched conti-ol dot plot, 10,000 
events were acquired. Results are 
representative  of more  than  30 
experiments. 
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Figure 2.  The day 5 precursors display  a discrete phenotype. Cord blood CD34  + HPC were cultured for 5-6 d in presence of GM-CSF+TNFIx. The 
phenotype of the different  populations  was determined by two-color analysis.  Cells were processed for double staining  using either uncoupled mAbs re- 
vealed by PE-conjugated  anti-mouse Ig or biotinylated  mAbs revealed by PE-conjugated  streptavidin  or PE~conjugated  mAbs. Then, after saturation  in 
5% mouse serum, cells were stained with anti-CD14-FlTC or anti-CDla-FITC.  20,000-50,000 events were acquired. Histograms show PE staining 
gated either on CDla  + cells (top) or on the CD14  + cells (bottom). White histograms  show the isotype matched controls. P,  esults are representative  of more 
than six experiments, mAbs were purchased as follows: CD2-PE ($5.2; Becton Dickinson),  CD9-PE (CBL-162; Cymbus Bioscience  LTD, Southamp- 
ton, UK), CD1 lb-PE (D12; Becton Dickinson),  CD32-PE (B73-I; Caltag Labs.), CD36-biotin (SMO; Ancell  Corporation, Bayport, MN), CD40 (mAb 
89; [mmunotech),  CD72 (BU040; Binding Site), c-fins (AB-2; Oncogene-Science,  Inc., Cambridge, MA). 
pearing and at  day  14,  most cells lack CD14  and express 
CDla. 
To confirm that CD14 + cells effectively acquired CDla 
and lost  CD14,  the  two  populations, CD14+CDla  -  and 
CD14-CD1a  +, were FACS|  at day 5-6. As shown 
in Fig. 1 B, upon reculture in GM-CSF+TNFcl for 7  ad- 
ditional days, the CD14+-derived cells expressed CDla and 
lack  CD14.  The  CDla+-derived cells  remained CD14-- 
CDla  +. 
To better characterize the two populations, an extensive 
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Figure 3.  The isolated day 5-6 dendritic cell precursors lack prolifera- 
tive capacity. Cord blood CD34  § HPC  were cultured in presence of 
GM-CSF+TNDx. After 5-6 d, cells were collected, processed for double 
staining using anti-CD14-PE and anti-CDla-FITC and FACS| 
into  CD14-CDla  +,  CD14+CD1a  -,  and  CD14 CDla  .  Sorted cells 
were seeded at 3 ￿  104 cells per well in round-bottomed microtest tissue 
culture plates in presence of medium alone, GM-CSF, TNFcx, GM- 
CSF+TNFcx, or M-CSF. Proliferation  was measured by 3H-TdR uptake 
after 3 d of culture. Results  are representative  of four experiments. 
phenotype was  performed by double staining at  day  5-6. 
Both populations are  negative for CD5,  7,  8,  15,  16,  21, 
24,  25,  34,  35,  45RA,  64,  83.  They  express  comparable 
levels of CD4, 11a, 11c, 13, 15S, 18, 26, 33, 38, 39, 40, 43, 
44, 45RO, 48, 49 (d and e), 50, 54, 58, 59, 74, 78, 80, 86 
and HLA class II. CDlb and CDlc were expressed at higher 
levels on CDla  + cells than on the CD14 + cells.  Conversely 
CD11b, CD32,  and CD36 were more intensely expressed 
on CD14 + cells than on CDla  + cells.  Interestingly, while 
CD72 was expressed on CDla + cells, this molecule was not 
detected  on  CD14 + cells.  On the  contrary,  only CD14 + 
cells bore CD2, CD9 and the M-CSF-R. Fig. 2  illustrates 
the  major  phenotypic  differences  observed  between  the 
two populations. Altogether, these results demonstrate that 
the two precursor populations, identified by the exclusive 
expression of CDla or CD14, differed by the expression of 
a set of molecules confirming that the two populations are 
unique and unrelated entities. 
DC Precursors Do Not Proliferate but Differentiate  into  Ma- 
ture DC.  To characterize the properties of the DC precur- 
sor populations and of their respective progenies, CD14 + 
and CDla + ceils were routinely FACS|  after cultur- 
ing CD34 + HPC with GM-CSF+TNF~+SCF  for 5-6 d. 
First  the  proliferative  capacity  of the  two  populations 
was  assessed  by  comparison  with  that  of CD14-CDla- 
cells.  Sorted cells were seeded at 3  ￿  104 cells per well in 
round-bottomed rnicrotest tissue culture plates with or with- 
out growth  factors  and the  proliferation was  assessed  3  d 
later by 3H-TdR uptake. As shown in Fig. 3, both CD14-- 
CDla + and CD14+CDla  -  failed to proliferate, while the 
double  negative  population  strongly  proliferated  in  re- 
sponse to GM-CSF or GM-CSF+TNFot. The lack of pro- 
liferative  capacity  of  CD14+CDla  -  and  CD14  CDla  + 
populations was  further confirmed in kinetic experiments 
based on the incorporation of Hoechst 33342 (not shown). 
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CDla and CD14 expression, they no longer can proliferate 
while the precursors lacking CDla and CD14 can still pro- 
liferate. 
The  differentiation  potential  of these  two  populations 
was  then  analyzed according  to  morphology  and  pheno- 
type upon reculturing in presence of GM-CSF+TNFoL  up 
until day 16. The morphology of the cells at different stages 
of culture/maturation is shown in Fig. 4. At day 6, the two 
subsets  contained  a relatively homogeneous population of 
medium  size  with  irregular  shape  (Fig.  4,  A  and E).  The 
CDla§  DC  developed  a  pronounced  dendritic 
morphology at day 9, maintained at day 12  (Fig.  4,  B--D), 
with  small  dendrites  homogeneously  distributed  over  the 
cell  surface.  The  dendritic  morphology  of CD14-derived 
DC developed at later time points (day 12 to day 16). The 
CD14+-derived DC are characterized by polarized lamelli- 
podia  (day  12,  Fig.  4,  F-H)  and some  cells  with  a veiled 
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Figure  4.  The day 5 DC pre- 
cursors differentiate at day 12-16 
into  cells  displaying  a  dendritic 
morphology.  Cord blood CD34  + 
HPC  were  cultured  in  presence 
of GM-CSF+TNF(x.  After 5-6 
d,  cells were  FACS|  into 
CD14-CD1a +  and  CD14*- 
CDla-. Sorted cells were seeded 
in presence of GM-CSF+TNF~x 
or M-CSF  (1-2  ￿  105  cells  per 
ml) for 6-7 additional days, a last 
medium  change  being  per- 
formed  at  day  10.  Cells  were 
processed for May Gri.inwald Gi- 
emsa  (MGG)  staining at  day  6, 
12,  and  16.  CDla-derived  DC 
cultured  in  GM-CSF+TNF(x 
are shown after MGG staining at 
day 6  (A)  and day 12  (B and C) 
and  by  phase  contrast  micros- 
copy  at  day  12  (D).  CD14- 
derived  DC  cultured  in  GM- 
CSF+TNF~  are  shown  after 
MGG  staining at day 6  (E),  day 
12 (Fand G), and day 16 (I) and 
by  phase  contrast  microscopy  at 
day  12  (H).  CD14-derived  DC 
cultured  in  M-CSF  are  shown 
after  MGG  staining  at  day  12 
(,J).  Magnification,  ￿  Re- 
sults  are  representative  of  four 
experiments. morphology can be observed at certain stages of differentia- 
tion (day 12-16, Fig. 4, F-I). 
In terms ofphenotype (Fig. 5 A), at day 14 both popula- 
tions  yield cells  expressing molecules  expected on  active 
DC including high levels of MHC class II, CD80,  CD86, 
CD40, and the DC-specific marker CD83 and the intracy- 
toplasmic molecule $100~3 (Fig. 6, A and B). The two pop- 
ulations also expressed similar levels ofCDlc, CD4, CD1 la, 
CDllc,  CD13,  CD15s,  CD18,  CD33,  CD43,  CD44, 
CD45RO,  CD48, CD49e, CD49d, CD50, CD54, CD58, 
CD59,  CD71,  CD74,  CD78.  The  phenotype of mature 
DC  was  usually  observed  earlier  on  the  CDla+-derived 
DC (day 10-12) than on the CD14+-derived DC (day 14-- 
16) (not shown). 
Taken together these results  show that the two DC pre- 
cursor populations isolated at day 5-6 differentiate, at day 
12-16, into cells with a characteristic DC morphology and 
phenotype. 
The  Two  DC  Populations Display  Different Characteristics. 
Although the two cell populations have a phenotype char- 
acteristic of DC, some major phenotypic differences could 
be observed at day 14. As shown in Fig.  5 B, the CDla +- 
derived DC express low levels of CD72 and high levels of 
the E-cadherin, a molecule expressed on LC and involved 
in homophilic interactions between keratinocytes and LC 
in  the  epidermis  (26,  27).  In  addition,  immunostaining 
(Fig. 6, C and D) show that CDla+-derived DC (19-34%) 
express  the  antigen  Lag  (Langerhans-associated  granule, 
(25)).  On  the  contrary, CD14+-derived DC  lack  CD72, 
the Lag antigen and E-cadherin.  Furthermore, in  contrast 
to  CDla-derived  cells,  CD14-derived  cells  display  CD9, 
CD2,  FCyRII/CD32, and the intracytoplasrmc CD68  (see 
also  Fig.  6,  E  and F).  Finally, at day  14,  CD14+-derived 
DC  still  express  the  complement  receptor  CD11b  (12- 
35%)  as  well  as  CD36  (all the  cells),  not  detected  on 
CDla+-derived  DC.  At  day  16-18  these  two  molecules 
were lost on CD14-derived DC (not shown). Also expres- 
sion of Factor XIlla, a procoagulation factor described on 
dermal DC  but not on epidermal LC,  has  been detected 
only on the  CD14+-derived DC  (Fig.  6,  G  and H).  The 
restricted  expression  of  Factor  XIIIa  on  the  CD14  +- 
derived DC has been confirmed by RT-PC1K (not shown). 
The two cell populations were also analyzed by electron 
microscopy.  At  day  13,  the  two  cell  populations  had  a 
characteristic dendritic cell shape and a typical multilobed 
nucleus.  However, as shown in Fig.  7,  only the  CDla +- 
derived DC were found to develop Birbeck granules. Be- 
tween 12 and  14% of cells in the total population express 
Birbeck  granules  against  31-56%  in  the  CDla+-derived 
DC population and 0--1% in the CD14+-derived DC pop- 
ulation. In all experiments, and at any time point tested be- 
yond day 6  (from day 13 to 16),  the CDla+-derived DC 
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Figure  5.  The day 5 dendritic 
cell precursors differentiate at day 
14 into cells with typical  dendritic 
cell  antigens  as  well  as  discrete 
markers. Cord blood CD34+ HPC 
were cultured in presence of GM- 
CSF+TNF0t.  After  5--6  d  cells 
were FACS|  into CD14- 
CDla § and CD14+CDla -. Sorted 
cells  were seeded in presence of 
GM-CSF+TNFa  (1-2  X  10  ~ 
cells  per  ml)  for  6-7  additional 
days, a last medium change being 
performed at day  10.  At day  14 
the phenotype of the two popu- 
lations was determined by single 
color analysis.  Cells were stained 
using  either  uncoupled  mAbs 
revealed by PE-conjugated anti- 
mouse Ig or biotinylated mAbs re- 
vealed by PE-conjugated strepta- 
vidin  or  PE-conjugated  mAbs. 
5,000 events were acquired. White 
histograms  show  the  isotype 
matched controls. Results are rep- 
resentative of more than six ex- 
periments. (A) Dendritic cell an- 
tigens.  (B) Discrete markers, mAbs 
were  purchased  as  followed: 
CD68,  (EMBll;  Dako),  CD80- 
PE  (L307.4;  Becton  Dickinson), 
CD83  (HB15a;  kindly provided 
by Zhou and Tedder), CD86-PE 
(1T2.2;  PharMingen),  E-cadherin 
(Hecd-1 ; Takara). 
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intracytoplasmic molecules re- 
vealed  phenotypic differences 
between  the  two  DC  popula- 
tions. CDla- and CD14-derived 
DC  subpopulations were ob- 
tained as  described in Materials 
and Methods and legends of Figs. 
2 and 5.  At day  12,  cells were 
fixed and processed for immu- 
nostaining. Cells were stained 
with  mAbs anti-S100[3 (A  and 
B), anti-Lag  (C and D), and anti- 
CD68 (E and F) and polyclonal 
anti-Factor XIlla  (G  and  H). 
CDla-derived DC are shown in 
A, C, E,  G, and CD14-derived 
DC in B, D, F, and H. No stain- 
ing was detected with mAb and 
polyclonal  matched controls (not 
shown).  Magnification, ￿ 
Results are representative  of three 
experiments. 
population  always  contained cells  with  Birbeck  granules 
while the CD14+-derived DC population never contained 
cells with Birbeck granules (~<1%). 
Thus,  CDla  +  precursors  yield  typical  epidermal  LC 
characterized by the expression of CDla, Birbeck granules, 
Lag antigen, and E-cadherin, while the CD14 + precursors 
homogeneously differentiate into DC with features of der- 
mal DC and blood DC such as Factor XIIIa, CD68, CD9, 
and CD2 expression. 
The  CD14+ CD1a -  Precursors Differentiate  into  Macrophage- 
like Cells in Response to M-CSF.  As shown in Fig. 2, CD14 + 
precursors express the M-CSF-P,. while CDla  + precursors 
do not. Thus, the effects of M-CSF on the differentiation 
of the two precursor populations was analyzed in compari- 
son  to  that  of  GM-CSF+TNFe~.  After  7-8  additional 
days of culture with M-CSF, CD14  + cells remained alive 
while CDla  + cells were lost. As shown in Fig. 8 A, CD14  + 
precursors cultured in presence of M-CSF differentiate into 
701  Caux et al. Figure 7.  Only CDla+-derived DC develop Birbeck granules at day 13. CDla- and CD14-derived DC subpopulations were obtained as described in 
Materials and Methods and legends of Figs. 2 and 5. At day 13, cells were fixed and processed for electron microscopy observation. A represents Cl)la- 
derived DC and B represents CD 14-derived DC. Bars represent 1 p,m. Insets in A represent higher magnification (X 8) of  Birbeck granules. Between 1(70 
and 200 cells were observed for each condition. At day 6, Birbeck granules were never detected. At day 13, the cells expressing  Birbeck granules repre- 
sent 12-14%, 31-56%, and 0-1% of bulk, CDla  + and CD14 ~ populations, respectively. Percentages represent ranges from more than four experiments. 
CD14+CDla -  cells contrasting with the CD14-CD1a + cells 
generated in presence of GM-CSF+TNFoL.  Furthermore, 
the M-CSF-derived ceils were characterized by the lack of 
CD2,  CD40,  CD80,  and CD83  expression, lower levels of 
CD86,  HLA-DR  and  HLA-DQ  (not  shown)  and  higher 
levels of CD9 and CD 1 lb. In term of morphology, as shown 
in  Fig.  4 J,  the  M-CSF-derived cells,  displayed a  macro- 
phage like morphology with numerous vacuoles, contrasting 
with  the  dendritic morphology of the  GM-CSF+TNFo~- 
derived cells. These differentiation events occurred without 
proliferation as shown in Fig. 3. 
Thus, the CD14 + precursors display a double differentia- 
tion  potential as they can  be induced to  differentiate into 
either  DC  in  response  to  GM-CSF+TNFcx  or  macro- 
phage-like  cells  in  response  to  M-CSF.  In  contrast,  the 
CDla + precursors  have  a  unique  differentiation potential 
towards LC. 
The Two DC Populations Are Equally  Potent in Stimulating 
Naive  T  Cell Proliferation.  Activation of naive T  cells being 
the functional characteristic of dendritic cells, the two mature 
DC populations were analyzed with regard to  their ability 
to induce allogeneic CD451KA + naive T  cells proliferation. 
CD45RA +  naive  T  cells  were  isolated  either  from  adult 
peripheral blood (Fig. 9 A) or from cord blood (Fig. 9  B). 
At  day  14,  comparable  stimulatory  capacities  of the  two 
DC populations were observed. Half maximal proliferation 
of CD45RA +  T  cells from either adult or cord blood was 
obtained  with  100-200  CDla +-  or  CD14+-derived  DC. 
As few as  10  cells of any populations were  able to  induce 
significant  naive  T  cell  proliferation  (>100-fold  back- 
ground values). In contrast CD14+-derived cells recovered 
after M-CSF  culture lacked stimulatory capacity for naive 
T  cell proliferation (Fig. 9  C).  Between  3  X  103-104  ceils 
were  required  to  induce  a  significant T  cell proliferation, 
1,000-fold more M-CSF-derived cells were required to in- 
duce  levels  of  T  cell  proliferation  observed  with  GM- 
CSF+TNFc~-derived  cells.  Thus  in  addition to  morpho- 
logic  and  phenotypic  characteristics  of  dendritic  cells 
CDla +-  and  CD14+-derived  cells  have  the  functional 
property of dendritic cells, i.e., potent induction of naive T 
cell proliferation. 
Discussion 
Previous studies in humans and mice have demonstrated 
the central role of GM-CSF in the generation of DC from 
hematopoietic progenitor cells. Here,  we demonstrate that 
under  a  unique  culture  condition  (GM-CSF+TNFo 0, 
CD34 + HPC are induced to differentiate along two distinct 
DC pathways. After 3-7 d  of culture, two precursor popu- 
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Figure 8.  Only CD14 precur- 
sors  cultured  in  presence  of 
M-CSF differentiate into mono- 
cyte/macrophage-like  cells. (A) 
Cord blood CD34 + HPC were 
cultured  in  presence  of  GM- 
CSF+TNFet. After 5-6  d  cells 
were FACS|  into CD14-- 
CDla  +  and  CD14+CDla -. 
Sorted cells were seeded in pres- 
ence  of  GM-CSF+TNF~t  or 
M-CSF (1-2 ￿  10  s cells per ml) 
for  7-8  additional  days, a  last 
medium change being performed 
at day 10. At day 14, cells were 
reanalyzed for CDla and CD14 
expression by single-color fluo- 
rescence  using  anti-CDla-PE 
and auti-CD14-PE. 5,000 events 
were acquired. White histograms 
show the isotype match controls. 
Results are representative of five 
experiments. (B)  CD14  precur- 
sors isolated at day 5-6 (see leg- 
ends to Figs. 2 and 5) were cul- 
tured in presence of GM-CSF+ 
TNFct or M-CSF. At day 14, the 
phenotype of the cells was deter- 
mined  by  single color  analysis 
(see legend to Fig. 5.5,000 events 
were acquired. The phenotype of 
CI) 14  precursors cultured  in 
M-CSF  (gray) or in  GM-CSF+ 
TNFc~ (white)  is shown. Results 
are representative of three exper- 
iments. 
lations, characterized by the reciprocal expression of CDla 
or CD14  antigens,  emerge  independently. Each precursor 
population expresses a unique pattern of surface molecules: 
CDla + precursors specifically bearing CD72 while CD14 + 
precursors express CD9, CD1 lb, CD36, and the M-CSF-R. 
In response to GM-CSF+TNF0t,  both populations mature 
at  day  12-16  into  DC  characterized by a  dendritic mor- 
phology,  a  phenotype  of DC  (high  HLA  class  I  and  II, 
CDla +, CD83 +, CD86 +, CD40 +, CD14-)  and the capac- 
ity to  activate  naive  CD45RA +  cord blood  T  cells.  The 
CDla-derived DC  mature,  at day 12,  into typical LC ac- 
cording  to  the  expression  of Birbeck granules,  intracyto- 
plasmic Lag molecule and of surface E-cadherin,  all borne 
by  epidermal LC  (25,  26,  27).  The  CD14+-derived  cells 
mature,  at day  14-16,  into  DC  that lack the  LC  antigens 
Lag and E-cadherin as well as Birbeck granules but express 
Factor XlIIa, CD11b, and CD36, markers of dermal (inter- 
stitial) dendritic cells (6,  7).  CD14+-derived DC,  in  con- 
trast  to  CDla-derived  DC,  also  express  CD9  and  CD2 
molecules,  which  have  been  identified on  circulating pe- 
ripheral blood DC  (2, 28, 29). 
Our study challenges the  concept that  the  DC  popula- 
tions observed in vivo may indeed represent different stages 
of maturation/activation of the same DC lineage and raises 
the question about the relationship that exists between these 
in vitro DC populations, the in vivo ones and their specific 
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early  hematopoietic  progenitors.  Our  results  suggest  that 
LC may represent an epithelial specific cell directly arising 
from precursors such as circulating CD34 + cells that could 
mature locally. By contrast, the circulating peripheral blood 
DC might represent cells in migration from the bone mar- 
row to the peripheral organs (e.g., dermis, liver, kidney . . .) 
or from  the  peripheral organs  to  secondary lymphoid or- 
gans (e.g., spleen, lymph nodes). Our present findings would 
be  consistent  with  the  observations  in  rel-B  knock-out 
mice which  have  normal LC but  lack interdigitating cells 
(30, 31). 
The  CDla+-derived DC  (epithelial DC  type) may rep- 
resent an  independent pathway  of development unrelated 
to  monocytes.  In  contrast,  the  CD14+-derived  DC  are 
likely linked to the monocyte lineage for the following rea- 
sons: (a) at certain stage of maturation, they share with mono- 
cytes, a number of molecules such as CD14, CD11b, CD36, 
and CD68;  (b) they transiently display non-specific=esterase 
activity, a  marker  of scavengers while  CDla-derived DC 
do not  (manuscript in preparation);  (c)  upon M=CSF acti- 
vation,  CD14 + precursors  differentiate  into  macrophage- 
like cells lacking accessory function for T  cells, as recently 
described (32), while CDla + precursors do not respond to 
M-CSF, presumably because of the absence of M-CSF-P, 
expression.  In line  with  this  hypothesis,  peripheral blood 
monocytes  which  differentiate  into  macrophages  in  re- 2oo, 
150- 
! 
A  Adutt T cells 
i CDI~  ~ 
....  ,;. 
number Of stlmuiator  cells 
300" 
"~  2oo 
i 
.I 
D,  Cord blood T cells 
number of Mlmulator  cells 
2so' C  GM-CSF+TNF  versus M-CSF 
i  c= 1 
100  G~F~TNF~ 
5O 
number of stimulator  ceils 
Figure 9.  The two DC subpopulations display overlapping naive T cell 
activation properties. Cord blood CD34 + HPC were cultured in presence 
of GM-CSF  + TNFcx. After 5-6 d, cells were FACS|  into CD 14 - - 
CDla  + and CD14+CD1a -. Sorted cells were seeded (1-2 X 10  s cells per 
ml) in presence of GM-CSF+TNFcx (A and B), or M-CSF (C) for 7-8 
additional days, a last medium change being performed at day 10. (A and 
B) Cells were recovered at day 14, after culture in GM-CSF+TNFcx, and 
used after irradiation  (30 Gy) as stimulator cells for  adult  (A) or cord 
blood (B) naive CD45RA  + T cells (2 X 104 cell per well). (C) CD14 +- 
sponses to  M-CSF  (33),  have  been shown to  differentiate 
into DC upon activation with GM-CSF+IL-4  (34-36). 
The existence of different pathway  of DC  development 
is indeed supported by the description, in mice, of thymic 
DC originating from hematopoietic precursors with a lym- 
phoid  differentiation  potential  contrasting  with  myeloid 
precursors yielding splenic DC  (10,  14, 37). In this context, 
a CD10 + CD34 + HPC  able to differentiate into DC, T, B, 
and NK cells but not into myeloid cells has also been iden- 
tified in humans  (11),  thereby  supporting the  notion that 
one type of DC  is developmentally more closely related to 
the  lymphoid lineage  than  to  the  myeloid lineage.  These 
cells might  actually correspond  to  the  presently  described 
CDla+-derived DC  which  originates from  early  CD38  l~ 
CD34 + HPC  (not shown). This CDla+-derived DC prob- 
ably corresponds to the CFU-DC  progenitor yielding pure 
DC colonies identified by Young et al. (38). Further exper- 
iments  are  required  to  formally  establish  this  hypothesis. 
On the contrary, the CD14+-derived DC are clearly devel- 
opmentally linked to  the  myeloid lineage as illustrated by 
the  isolation  of  CD14+CDla -  common  precursors  that 
can  yield  either  macrophages  in  response  to  M-CSF  or 
dendritic  cells  in  response  to  GM-CSF+TNFot.  In  sum- 
mary, this study demonstrates that CD34 + HPC  yield two 
separate precursors, CD14-CD1a + and CD14+CD1a -, that 
can  differentiate without  proliferating into phenotypically 
distinct  dendritic  cells  respectively  corresponding  to  epi- 
dermal and interstitial/dermal DC. 
derived cells were recovered at day 14, after culture with GM-CSF  + TNFc~ 
or with M-CSF and used after irradiation (30 Gy) as stimulator cells for 
adult naive CD45RA  + T cells (2 ￿  104 cell per well). The proliferation 
was revealed by 3H-TdR uptake after 5 d of culture. Results are expressed 
as mean cpm +  SD of triplicate cultures. Results of each panel are repre- 
sentative of three experiments or more. 
We are grateful to I. Durand and E. Garcia for FACS  |  analysis and FACS  |  sorting; N. Courbi~re, S. Bon- 
net-Amaud and M. Vatan for editorial assistance; doctors and colleagues from clinics and hospitals  in Lyon 
who provided us with umbilical cord blood samples; Dr. J. Chiller and Dr. D. Capra for support and for dis- 
cussions. 
Address  correspondence to  Christophe  Caux,  Schering-Plough, 27  chemin de  Peupliers, BP  11,  69571, 
Dardilly, France. 
Received  for publication 21 March 1996 and in revised  form 6June 1996. 
References 
1.  Steinman, R..M.  1991. The dendritic cell system and its role 
in immunogenicity. Annu. Rev. Immunol. 9:271-296. 
2.  O'Doherty,  U.,  M.  Peng,  S.  Gezelter,  W.J.  Swiggard,  M. 
Betjes,  N.  Bhardwaj,  and  P,.M.  Steinman.  1994.  Human 
blood contains two subsets of dendritic cells,  one immuno- 
logically mature  and  the  other  immature.  Immunology. 82: 
487-493. 
3.  Thomas, R., L.S. Davis, and P.E. Lipsky. 1993. Isolation and 
characterization of human peripheral blood dendritic cells. J. 
Immunol. 150:821-834. 
4.  Thomas, 1K., and P.E. Lipsky. 1994. Human peripheral blood 
dendritic cell subsets. Isolation and characterization ofprecur- 
704  Identification of Two Dendritic Cell Pathways from Human Cord Blood sor  and  mature  antigen-presenting  cells. J.  Immunol.  153: 
4016-4028. 
5.  Weissman, D., Y. Li, J. Ananworanich, L.-J. Zhou, J. Adels- 
berger, T.F. Tedder, M. Baseler, and A.S. Fauci. 1995.  Three 
populations of cells with dendritic morphology exist in pe- 
ripheral blood, only one of which is infectable with human 
immunodeficiency virus type 1. Pro& Natl.  Acad.  Sci. USA. 92: 
826-830. 
6.  Lenz, A., M. Heine, G. Schuler, and N. Romani. 1993.  Hu- 
man and murine dermis contain dendritic cells..],  Clin.  Invest. 
92:2587-2596. 
7.  Nestle, F.O., X.-G. Zheng, C.B. Thompson, L.A. Turka, and 
B.J.  Nickoloff.  1993.  Characterization  of dermal  dendritic 
cells obtained from normal human skin reveals phenotypic and 
functionally distinctive subsets. J.  Immunol.  151:6535-6545. 
8.  Agger, R.,  M.  Witmer-Pack, N.  Romani,  H.  Stossel,  W.J. 
Swiggard, J.P.  Metlay,  E.  Storozynsky,  P.  Freimuth,  and 
R.M. Steinman.  1992.  Two populations of splenic dendritic 
cells detected with M342, a new monoclonal to an intracellu- 
lar antigen of interdigitating dendritic cells and some B lym- 
phocytes.J. Leukocyte  Biol.  52:34-42. 
9.  Kelsall,  B.L., and W.  Strober.  1996.  Distinct populations of 
dendritic cells are present in the subepithelial dome and T cell 
regions of  the murine Peyer's patch.J. Exp. Med. 183:237-247. 
10. Ardavin, C., L. Wu, C.L. Li, and K. Shortman.  1993.  Thy- 
mic dendritic cells and T  cells develop simultaneously in the 
thymus from a common precursor population. Nature (Lond.). 
362:761-763. 
11. Galy, A., M. Travis, D. Cen, and B. Chen.  1995.  Human T, 
B,  natural  killer, and  dendritic  cells  arise from  a  common 
bone marrow progenitor cell subset.  Immunity. 3:459-473. 
12.  Inaba, K., R.M. Steinman, M.W. Pack, H. Aya, M. Inaba, T. 
Sudo, S. Wolpe, and G. Schuler. 1992.  Identification of pro- 
liferating dendritic cell precursors in  mouse  blood. J.  Exp. 
Med.  175:1157-1167. 
13.  Inaba,  K., M.  Inaba,  N.  Romani,  H.  Aya, M.  Degnchi,  S. 
lkehara, S. Muramatsu,  and R.M.  Steinman.  1992.  Genera- 
tion  of large  numbers  of dendritic cells  from  mouse  bone 
marrow cultures supplemented with granulocyte/macrophage 
colony-stimulating factor..]. Exp.  Med.  176:1693-1702. 
14.  Inaba, K., M. Inaba, M. Deguchi, K. Hagi, R. Yasumizu, S. 
Ikehara, S. Muramatsu, and R.M. Steinman. 1993.  Granulo- 
cytes, macrophages, and dendritic cells arise from a common 
major histocompatibility  complex class lI-negative progenitor 
in mouse bone marrow. Proc. Natl. Acad.  Sci. USA. 90:3038- 
3042. 
15.  Caux, C., C. Dezutter-Dambuyant, D. Schmitt, and J. Ban- 
chereau. 1992.  GM-CSF and TNF-(x cooperate in the gener- 
ation of dendritic Langerhans cells. Nature (Lond.). 360:258-261. 
16. Reid,  C.D.L.,  A.  Stackpoole, A.  Meager,  and J.  Tikerpae. 
1992.  Interactions of tumor necrosis factor with granulocyte- 
macrophage colony-stimulating factor and other cytokines in 
the regulation of dendritic cell growth in vitro from early bi- 
potent CD34 § progenitors in human bone marrow. J. Immu- 
nol.  149:2681-2688. 
17. Santiago-Schwarz, F., E. Belilos, B. Diamond, and S.E. Car- 
sons.  1992.  TNF  in  combination with  GM-CSF  enhances 
the differentiation of neonatal cord blood stem cells into den- 
dritic cells and macrophages.J. Leukocyte  Biol.  52:274-281. 
18. Szabolcs, P., M.A.S. Moore, andJ.W. Young.  1995.  Expan- 
sion of immunostimulatory dendritic cells among the  rnye- 
loid progeny of human CD34 + bone marrow precursors cul- 
tured with  c-kit-ligand, GM-CSF, and  TNFo~. J.  lmmunol. 
154:5851-5861. 
19. Gluckman, J.C., M. Rosenzwajg, and B. Canque.  1996.  Hu- 
man dendritic cell differentiation pathway from CD34 + he- 
matopoietic precursor cells. Blood. 87:535-544. 
20. Caux, C., I. Durand, I. Moreau, V. Duvert, S. Saeland, andJ. 
Banchereau.  1993.  TNFcx cooperates with  IL-3  in  the  re- 
cruitment of a  primitive subset of human  CD34 + progeni- 
tors.J. Exp. Med. 177:1815-1820. 
21. Caux, C., S. Saeland, C. Favre, V. Duvert, P. Mannoni, and 
J.  Banchereau.  1990.  Tumor  necrosis factor-alpha strongly 
potentiates  interleukin-3  and  granulocyte-macrophage col- 
ony-stimulating factor-induced proliferation of human CD34 + 
hematopoietic progenitor cells. Blood. 75:2292-2298. 
22.  Caux,  C.,  C.  Favre,  S.  Saeland,  V.  Duvert,  I.  Durand,  P. 
Mannoni, and J. Banchereau.  1991.  Potentiation of early he- 
matopoiesis by tumor necrosis factor-a is followed by inhibi- 
tion ofgranulopoietic differentiation and proliferation. Blood. 
78:635-644. 
23. Miltenyi,  S.,  W.  Mfiller,  W.  Weichel,  and  A.  Radbruch. 
1990.  High gradient magnetic cell separation with Macs. Cy- 
tometry. 11:231-238. 
24. Vallt, A., C.E. Zuber, T. Defrance, O. Djossou, M. de Rie, 
and J.  Banchereau.  1989.  Activation of human  B  lympho- 
cytes through CD40  and interleukin 4.  Eur. J.  Immunol.  19: 
1463-1467. 
25. Kashihara,  M.,  M.  Ueda,  Y.  Horignchi,  F.  Furukawa,  M. 
Hanaoka,  and  S.  Imamura.  1986.  A  monoclonal  antibody 
specifically reactive to human Langerhans cells. J.  Invest.  Der- 
matol. 87:602-607. 
26. Tang, A., M. Amagai, L.G. Granger, J.R. Stanley, and M.C. 
Udey. 1993. Adhesion ofepiderrnal Langerhans cells to kera- 
tinocytes mediated by E-cadherin. Nature (Lond.).  361:82-85. 
27.  Blauvelt, A., S.I. Katz, and M.C. Udey. 1995. Human Langer- 
hans cells express E-cadherin.J. Invest. Dermatol. 104:293--296. 
28. Zhou, L.-J., and T.F. Tedder.  1995.  Human blood dendritic 
cells selectively express CD83, a member of the immunoglo- 
bulin superfamilyJ. Immunol.  154:3821-3835. 
29.  O'Doherty, U., R.M. Steinman, M. Peng, P.U. Cameron, S. 
Gezelter,  I.  Kopeloff,  W.J.  Swiggard,  M.  Pope,  and  N. 
Bhardwaj.  1993.  Dendritic cells freshly isolated from human 
blood express CD4 and mature into typical immunostimula- 
tory  dendritic  cells  after  culture  in  monocyte-conditioned 
medium.J. Exp.  Med.  178:1067-1078. 
30.  Burkly, L.,  C.  Hession, L.  Ogata,  C.  Reilly, L.A. Marconi, 
D.  Olson, R.  Tizard, R. Cate, and D. Lo.  1995.  Expression 
of relB  is required for the  development of thymic medulla 
and dendritic cells. Nature (Lond.).  373:531-536. 
31.  Weih,  F.,  D.  Carrasco,  8.K.  Durham,  D.S.  Barton,  C.A. 
Rizzo, R.-P. Ryseck, S.A. Lira, and R. Bravo.  1995.  Multi- 
organ inflammation and hematopoietic abnormalities in mice 
with a targeted disruption ofRelB, a member of the NF-Ic]3/ 
Rel family. Cell. 80:331-340. 
32.  Szabolcs,  P.,  D.  Avigan, S.  Gezelter, D.H.  Ciocon, M.A.S. 
Moore, R.M.  Steinman, and J.W.  Young.  1996.  Dendritic 
cells and macrophages can mature independently from a hu- 
man  bone  marrow-derived, post-CFU  intermediate.  Blood. 
87:4520--4530. 
33. Young, D.A., L.D. Lowe, and S.C. Clark. 1990.  Comparison 
of the effects of IL-3, granulocyte-macrophage colony-stimu- 
lating factor,  and  macrophage  colony-stimulating factor  in 
supporting monocyte differentiation in  culture. J.  Immunol. 
145:607-615. 
34. Sallusto,  F., and A. Lanzavecchia. 1994.  Efficient presentation 
705  Caux et al. of soluble antigen by cultured human dendritic cells is main- 
tained by granulocyte/macrophage colony-stimulating  factor 
plus interleukin 4 and downregulated by tumor necrosis fac- 
tor alpha.J. Exp.  Med. 179:1109-1118. 
35. Sallusto, F., M. Cella, C. Danieli, and A. Lanzavecchia.  1995. 
Dendritic cells use macropinocytosis  and the mannose recep- 
tor to concentrate macromolecules in the major histocompat- 
ibility complex class II compartment: down-regulation  by cy- 
tokines and bacterial products.J. Exp. Mecl. 182:389-400. 
36.1komani, N., S. Gruner, D. Brang, E. K~impgen, A. Lenz, B. 
Trockenbacher, G.  Konwalinka, P.O.  Fritsch,  lL.M.  Stein- 
man, and G.  Schuler.  1994. Proliferating dendritic cell pro- 
37. 
38. 
genitors in human blood.J. Exp. Med.  180:83-93. 
Wu,  U,  D.  Vremec,  C.  Ardavin, K.  Winkel, G.  Suss, H. 
Georgiou,  E.  Maraskovsky,  W.  Cook,  and  K.  Shortman. 
1995. Mouse thymus dendritic cells: kinetics of development 
and changes in surface markers during maturation. Eur. J. Im- 
munol. 25:418-425. 
Young, J.W., P. Szabolcs, and M.A.S. Moore. 1995. Identifi- 
cation of dendritic cell colony-forming units among normal 
human CD34 + bone marrow progenitors that are expanded 
by c-kit-ligand  and yield pure dendritic cell colonies in the 
presence  of granulocyte/macrophage colony-stimulating  fac- 
tor and tumor necrosis factor c~. J. Exp. Med. 182:1111-1120. 
706  Identification of Two Dendritic Cell Pathways from Human Cord Blood 